Global Psoriasis Therapeutics Market 2012-2016

世界の乾せん症治療市場動向(2012-2016)

◆タイトル:Global Psoriasis Therapeutics Market 2012-2016
◆商品コード:IRTNTR2540
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2013年8月16日
◆ページ数:56
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の乾せん症治療市場動向(2012-2016)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、主要地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

TechNavio’s analysts forecast the Global Psoriasis Therapeutics market to grow at a CAGR of 4.06 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing uptake of biologics. The Global Psoriasis Therapeutics market has also been witnessing an increased focus on using combination therapies for treating psoriasis. However, the adverse side effects associated with psoriatic drugs could pose a challenge to the growth of this market.
TechNavio’s report, the Global Psoriasis Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Amgen Inc., Pfizer Inc., Janssen Biotech Inc., and Abbvie Inc.
The other vendors mentioned in the report are AstraZeneca plc, Bristol Myers Squibb Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., and Novartis International AG
UCB S.A. Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Types of Psoriasis
06.1 Types of Psoriasis Based on Forms
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Erythrodermic psoriasis
Pustular Psoriasis
06.2 Types of Psoriasis Based on Severity of Disease
07. Market Landscape
07.1 Global Psoriasis Therapeutics Market
Market Size and Forecast
07.2 Global Mild Psoriasis Therapeutics Market
07.3 Global Moderate Psoriasis Therapeutics Market
07.4 Global Severe Psoriasis Therapeutics Market
07.5 Five Forces Analysis
08. Geographical Segmentation
09. Rate of Incidence and Prevalence
Global Incidence and Prevalence
America
The UK
Asia
10. Pipeline Analysis
10.1 Topical Treatment Pipeline Analysis
10.2 Oral Treatment Pipeline Analysis
10.3 Injectable Treatment Pipeline Analysis
11. Vendor Landscape
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Key Vendor Analysis
18.1 Abbvie Inc.
Business Overview
Key Information
SWOT Analysis
18.2 Amgen Inc.
Business Overview
Key Information
SWOT Analysis
18.3 Janssen Biotech Inc.
Business Overview
Key Information
SWOT Analysis
18.4 Novartis International AG
Business Overview
Key Information
SWOT Analysis
18.5 Pfizer Inc.
Business Overview
Key Information
SWOT Analysis
19. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Psoriasis Based on Forms
Exhibit 3: Types of Psoriasis Based on Severity of Disease
Exhibit 4: Types of Psoriasis Based on Severity of Disease 2012
Exhibit 5: Global Psoriasis Therapeutics Market 2012-2016 (US$ billion)
Exhibit 6: Global Mild Psoriasis Therapeutics Market 2012 (in percentage)
Exhibit 7: Global Moderate Psoriasis Therapeutics Market 2012 (in percentage)
Exhibit 8: Global Severe Psoriasis Therapeutics Market 2012 (in percentage)
Exhibit 9: Global Psoriasis Therapeutics Market by Geographical Segmentation 2012
Exhibit 10: Business Segmentation of Novartis International AG
Exhibit 11: Business Segmentation of Pfizer Inc.



【掲載企業】

Amgen Inc., Pfizer Inc., Janssen Biotech Inc., Abbvie Inc., AstraZeneca plc, Bristol Myers Squibb Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., and Novartis International AG

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の乾せん症治療市場動向(2012-2016)] (Global Psoriasis Therapeutics Market 2012-2016 / IRTNTR2540)販売に関する免責事項
[世界の乾せん症治療市場動向(2012-2016)] (Global Psoriasis Therapeutics Market 2012-2016 / IRTNTR2540)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆